MCP-1 antibody treatment enhances damage and impedes repair of the alveolar epithelium in influenza pneumonitis

American Journal of Respiratory Cell and Molecular Biology

Volumn 42, Issue 6, 2010, Pages 732-743

  Narasaraju, T ^a   Ng, H H ^a   Phoon, M C ^a   Chow, Vincent T K ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Alveolar epithelial regeneration; Apoptosis; Hepatocyte growth factor; Influenza pneumonitis; Monocyte chemoattractant protein 1

Indexed keywords

CYTOKINE ANTIBODY; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1 ANTIBODY; SCATTER FACTOR; UNCLASSIFIED DRUG; CCL2 PROTEIN, MOUSE; CXCL1 CHEMOKINE; CXCL1 PROTEIN, MOUSE; PEROXIDASE; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL HYPERPLASIA; CELL INFILTRATION; CELL ISOLATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPLANT; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLUENZA; INFLUENZA VIRUS A; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG HOMOGENATE; LUNG INJURY; LUNG LAVAGE; MOUSE; NICK END LABELING; NONHUMAN; PHAGOCYTOSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; TISSUE REGENERATION; TISSUE REPAIR; VIRUS PNEUMONIA; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BLOOD; BODY WEIGHT; CELL CULTURE; DISEASE MODEL; HUMAN; HYPERPLASIA; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG ALVEOLUS; METABOLISM; NEUTROPHIL CHEMOTAXIS; ORTHOMYXOVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; RESPIRATORY TRACT MUCOSA; TIME; VIROLOGY; VIRUS LOAD;

ANIMALIA; MUS; ORTHOMYXOVIRIDAE; SUIDAE;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; BLOTTING, WESTERN; BODY WEIGHT; BRONCHOALVEOLAR LAVAGE FLUID; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CXCL1; CHEMOTAXIS, LEUKOCYTE; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INFLUENZA A VIRUS; INJECTIONS, INTRAPERITONEAL; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PEROXIDASE; PNEUMONIA, VIRAL; PULMONARY ALVEOLI; RECOMBINANT PROTEINS; RESPIRATORY MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; VIRAL LOAD;

EID: 77953275185     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2008-0423OC     Document Type: Article

References (47)

1. Chow VT, Tambyah PA, Goh KT. To kill a mocking bird flu? Ann Acad Med Singapore 2008;37:451-453.
2. Lal SK, Chow VT. Avian influenza H5N1 virus: an emerging global pandemic. In: Lal SK, editor. Emerging viral diseases of Southeast Asia. Basel: Karger; 2007. pp. 59-77.
3. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, et al. The global circulation of seasonal influenza A (H3N2) viruses. Science 2008; 320:340-346.
4. Chen LM, Davis CT, Zhou H, Cox NJ, Donis RO. Genetic compatibility and virulence of reassortants derived from contemporary avian H5N1 and human H3N2 influenza A viruses. PLoS Pathog 2008;4: e1000072. (Pubitemid 351811519)
5. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-2615.
6. Narasaraju T, Sim MK, Ng HH, Phoon MC, Shanker N, Lal SK, Chow VT. Adaptation of human influenza H3N2 virus in a mouse pneumonitis model: insights into viral virulence, tissue tropism and host pathogenesis. Microbes Infect 2009;11:2-11.
7. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci USA 2004; 101:4620-4624. (Pubitemid 38437460)
8. Nicholls JM, Chan MC, Chan WY, Wong HK, Cheung CY, Kwong DL, Wong MP, Chui WH, Poon LL, Tsao SW, et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med 2007;13:147-149. (Pubitemid 46245761)
9. Ronni T, Sareneva T, Pirhonen J, Julkunen I. Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells. J Immunol 1995;154:2764-2774.
10. Hofmann P, Sprenger H, Kaufmann A, Bender A, Hasse C, Nain M, Gemsa D. Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response. J Leukoc Biol 1997;61:408-414. (Pubitemid 27219833)
11. Conn CA, McClellan JL, Maassab HF, Smitka CW, Majde JA, Kluger MJ. Cytokines and the acute phase response to influenza virus in mice. Am J Physiol 1995;268:R78-R84.
12. Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 1995;269:1583-1585.
13. Julkunen I, Melén K, Nyqvist M, Pirhonen J, Sareneva T, Matikainen S. Inflammatory responses in influenza A virus infection. Vaccine 2000; 19:S32-S37. (Pubitemid 32121717)
14. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 1994;91:3652-3656. (Pubitemid 24139489)
15. Huffnagle GB, Strieter RM, Standiford TJ, McDonald RA, Burdick MD, Kunkel SL, Toews GB. The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J Immunol 1995;155:4790-4797.
16. Speyer CL, Gao H, Rancilio NJ, Neff TA, Huffnagle GB, Sarma JV, Ward PA. Novel chemokine responsiveness and mobilization of neutrophils during sepsis. Am J Pathol 2004;165:2187-2196. (Pubitemid 39578395)
17. Dessing MC, van der Sluijs KF, Florquin S, van der Poll T. Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia. Clin Immunol 2007;125:328-336. (Pubitemid 350116710)
18. Nakano Y, Kasahara T, Mukaida N, Ko YC, Nakano M, Matsushima K. Protection against lethal bacterial infection in mice by monocytechemotactic and -activating factor. Infect Immun 1994;62:377-383. (Pubitemid 24033752)
19. Tumpey TM, García-Sastre A, Taubenberger JK, Palese P, Swayne DE, Pantin-Jackwood MJ, Schultz-Cherry S, Solórzano A, Van Rooijen N, Katz JM, et al. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 2005;79:14933-14944.
20. Kim HM, Lee YW, Lee KJ, Kim HS, Cho SW, van Rooijen N, Guan Y, Seo SH. Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs. J Virol 2008;82:4265-4274. (Pubitemid 351563664)
21. McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 2002;109: 707-712.
22. Stahlman MT, Gray ME, Hull WM, Whitsett JA. Immunolocalization of surfactant protein-D (SP-D) in human fetal, newborn, and adult tissues. J Histochem Cytochem 2002;50:651-660.
23. Leth-Larsen R, Zhong F, Chow VT, Holmskov U, Lu J. The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages. Immunobiology 2007;212:201-211. (Pubitemid 46505956)
24. Johnson MD, Widdicombe JH, Allen L, Barbry P, Dobbs LG. Alveolar epithelial type I cells contain transport proteins and transport sodium, supporting an active role for type I cells in regulation of lung liquid homeostasis. Proc Natl Acad Sci USA 2002;99:1966-1971. (Pubitemid 34168998)
25. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984;122:1450-1459. (Pubitemid 14073577)
26. Nakamura T, Teramoto H, Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA 1986;83:6489-6493. (Pubitemid 17174760)
27. Manson RJ, Leslie CC, McCormick-Shannon K, Deterding RR, Nakamura T, Rubin JS, Shannon JM. Hepatocyte growth factor is a growth factor for rat alveolar type II cells. Am J Respir Cell Mol Biol 1994;11:561-567.
28. Shiratori M, Michalopoulos G, Shinozuka H, Singh G, Ogasawara H, Katyal SL. Hepatocyte growth factor stimulates DNA synthesis in alveolar epithelial type II cells in vitro. Am J Respir Cell Mol Biol 1995;12:171-180.
29. Yaekashiwa M, Nakayama S, Ohnuma K, Sakai T, Abe T, Satoh K, Matsumoto K, Nakamura T, Takahashi T, Nukiwa T. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin: a morphologic study. Am J Respir Crit Care Med 1997;156:1937-1944. (Pubitemid 28011805)
30. Morimoto K, Amano H, Sonoda F, Baba M, Senba M, Yoshimine H, Yamamoto H, Ii T, Oishi K, Nagatake T. Alveolar macrophages that phagocytose apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in mice. Am J Respir Cell Mol Biol 2001; 24:608-615. (Pubitemid 32442769)
31. Narasaraju TA, Jin N, Narendranath CR, Chen Z, Gou D, Liu L. Protein nitration in rat lungs during hyperoxia exposure: a possible role of myeloperoxidase. Am J Physiol Lung Cell Mol Physiol 2003; 285:L1037-L1045. (Pubitemid 37310093)
32. Lim KM, Yeo WS, Chow VT. Antisense abrogation of DENN expression induces apoptosis of leukemia cells in vitro, causes tumor regression in vivo and alters the transcription of genes involved in apoptosis and the cell cycle. Int J Cancer 2004;109:24-37.
33. Liew KJ, Chow VT. Differential display RT-PCR analysis of ECV304 endothelial-like cells infected with dengue virus type 2 reveals messenger RNA expression profiles of multiple human genes involved in known and novel roles. J Med Virol 2004;72:597-609.
34. Shellito J, Kaltreider HB. Heterogeneity of immunologic function among subfractions of normal rat alveolar macrophages. Am Rev Respir Dis 1984;129:747-753. (Pubitemid 14104755)
35. Vozzelli MA, Mason SN, Whorton MH, Auten RL. Antimacrophage chemokine treatment prevents neutrophil and macrophage influx in hyperoxia-exposed newborn rat lung. Am J Physiol Lung Cell Mol Physiol 2004;286:L488-L493.
36. Matsukawa A, Hogaboam CM, Lukacs NW, Lincoln PM, Strieter RM, Kunkel SL. Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4. J Immunol 1999;163:6148-6154.
37. Wareing MD, Lyon A, Inglis C, Giannoni F, Charo I, Sarawar SR. Chemokine regulation of the inflammatory response to a low-dose influenza infection in CCR2-/- mice. J Leukoc Biol 2007;81:793-801. (Pubitemid 46393557)
38. Hartshorn KL, White MR, Shepherd V, Reid K, Jensenius JC, Crouch EC. Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am J Physiol 1997;273: L1156-L1166. (Pubitemid 127807592)
39. Crouch E, Hartshorn K, Ofek I. Collectins and pulmonary innate immunity. Immunol Rev 2000;173:52-65.
40. Li G, Siddiqui J, Hendry M, Akiyama J, Edmondson J, Brown C, Allen L, Levitt S, Poulain F, Hawgood S. Surfactant protein-A - deficient mice display an exaggerated early inflammatory response to a β-resistant strain of influenza A virus. Am J Respir Cell Mol Biol 2002;26:277-282. (Pubitemid 34170054)
41. Chen J, Chen Z, Chintagari NR, Bhaskaran M, Jin N, Narasaraju T, Liu L. Alveolar type I cells protect rat lung epithelium from oxidative injury. J Physiol 2006;572:625-638.
42. Gu J, Xie Z, Gao Z, Liu J, Korteweg C, Ye J, Lau LT, Lu J, Gao Z, Zhang B, et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 2007;370:1137-1145.
43. Uiprasertkul M, Kitphati R, Puthavathana P, Kriwong R, Kongchanagul A, Ungchusak K, Angkasekwinai S, Chokephaibulkit K, Srisook K, Vanprapar N, et al. Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans. Emerg Infect Dis 2007;13:708-712. (Pubitemid 46698732)
44. Herold S, Steinmueller M, von Wulffen W, Cakarova L, Pinto R, Pleschka S, Mack M, Kuziel WA, Corazza N, Brunner T, et al. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med 2008;205:3065-3077.
45. Amano H, Morimoto K, Senba M, Wang H, Ishida Y, Kumatori A, Yoshimine H, Oishi K, Mukaida N, Nagatake T. Essential contribution of monocyte chemoattractant protein-1/C-C chemokine ligand-2 to resolution and repair processes in acute bacterial pneumonia. J Immunol 2004;172:398-409. (Pubitemid 38020494)
46. Low QE, Drugea IA, Duffner LA, Quinn DG, Cook DN, Rollins BJ, Kovacs EJ, DiPietro LA. Wound healing in MIP-1a(-/-) and MCP-1(-/-) mice. Am J Pathol 2001;159:457-463.
47. Shukla MN, Rose JL, Ray R, Lathrop KL, Ray A, Ray P. Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7. Am J Respir Cell Mol Biol 2009;40:643-653.